Titan Wealth’s AbbVie ABBV Stock Holding History

Titan Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.74M	Sell	38,717 -699	-2%	-$150K	3.62%	11
2026 Q1	$8.57M	Buy	39,416 +3,754	+11%	+$833K	3.7%	8
2025 Q4	$8.15M	Buy	+35,662	New	+$8.12M	3.13%	17

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Titan Wealth's ABBV Position: Q2 2026 in Review

Titan Wealth reduced its AbbVie (ABBV) stake by 1.8% in Q2 2026, selling an estimated $150K and leaving 38,717 shares worth $9.74M. The position accounts for 3.62% of the portfolio, ranked #11.

Titan Wealth first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 4,208 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Titan Wealth held 38,717 shares of AbbVie worth $9.74M as of Q2 2026.
Titan Wealth sold 699 AbbVie shares in Q2 2026, an estimated $150K.
AbbVie made up 3.62% of Titan Wealth's portfolio in Q2 2026, its #11 holding.
Titan Wealth first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
4,208 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Titan Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.